Gland Pharma - Quaterly Results

A fair growth of 16.50% in the revenue at Rs. 11775.13 millions was reported in the December 2025 quarter as compared to Rs. 10107.82 millions during year-ago period.Net profit showed a marginal rise at Rs. 3078.47 millions for the quarter ended December 2025, as compared to corresponding quarter of last year.The company reported a good operating profit of 4818.34 millions compared to 4562.06 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202512	202412	% Var	202512	202412	% Var	202503	202403	% Var
Sales	11775.13	10107.82	16.50	32905.00	30857.96	6.63	41161.49	41674.28	-1.23
Other Income	602.07	650.64	-7.46	1975.40	1713.57	15.28	2150.75	1666.66	29.05
PBIDT	4818.34	4562.06	5.62	13528.99	12198.52	10.91	16576.93	15754.47	5.22
Interest	5.02	183.08	-97.26	119.08	193.91	-38.59	228.37	78.43	191.18
PBDT	4569.86	4378.98	4.36	13166.45	12004.61	9.68	16348.56	15676.04	4.29
Depreciation	445.30	437.67	1.74	1331.33	1261.99	5.49	1692.71	1621.07	4.42
PBT	4124.56	3941.31	4.65	11835.12	10742.62	10.17	14655.85	14054.97	4.28
TAX	1046.09	990.08	5.66	3044.12	2745.08	10.89	3758.32	3621.72	3.77
Deferred Tax	-55.97	39.16	-242.93	-49.63	68.72	-172.22	91.24	246.84	-63.04
PAT	3078.47	2951.23	4.31	8791.00	7997.54	9.92	10897.53	10433.25	4.45
Equity	164.76	164.75	0.01	164.76	164.75	0.01	164.76	164.71	0.03
PBIDTM(%)	40.92	45.13	-9.34	41.12	39.53	4.01	40.27	37.80	6.53